## Diagnosis: Crusted (Norwegian) Scabies **Key Point:** Crusted scabies is a severe, highly contagious variant of scabies characterized by hyperkeratotic crusted plaques, minimal visible burrows, and massive mite burden (up to 1 million mites per patient vs. 10–15 in typical scabies). It occurs in immunocompromised, elderly, or institutionalized patients. **High-Yield:** The diagnostic triad is: 1. Hyperkeratotic crusted plaques (not typical burrows) 2. Massive mite burden on microscopy (KOH mount shows numerous mites, eggs, fecal pellets) 3. Immunocompromised or institutionalized host (elderly nursing home resident) ## Pathophysiology and Risk Factors ```mermaid flowchart TD A[Immunocompromise or advanced age]:::outcome --> B[Impaired Th1/Th2 response]:::outcome B --> C[Failure to mount adequate inflammatory response]:::outcome C --> D[Uncontrolled mite proliferation]:::outcome D --> E[Hyperkeratotic crusted plaques]:::outcome E --> F[Massive mite burden<br/>1 million+ mites]:::outcome F --> G[High transmission risk]:::urgent G --> H[Institutional outbreaks]:::urgent ``` **Risk Factors for Crusted Scabies:** - Advanced age - HIV/AIDS (CD4 <200 cells/µL) - Organ transplant recipients - Chronic corticosteroid use - Leukemia, lymphoma - Dementia or inability to scratch/treat ## Management: Combination Systemic + Topical Therapy | Aspect | Standard Scabies | Crusted Scabies | |--------|---|---| | **First-line oral agent** | Ivermectin (if indicated) | Ivermectin 200 µg/kg | | **Dosing schedule** | Single dose or day 0 + day 14 | Day 0, 14, 21, 28 (may need 4+ doses) | | **Topical agent** | Permethrin 5% alone | Permethrin 5% OR sulfur 10% | | **Topical frequency** | Twice, 7 days apart | Daily or every other day | | **Duration** | 2–3 weeks | 4–8 weeks or until clinical cure | | **Contact tracing** | Essential | **Mandatory** — institutional control measures | **Clinical Pearl:** Crusted scabies is a **medical emergency** in institutional settings. A single patient can infect dozens of residents and staff. Immediate isolation and treatment of all contacts is mandatory. ## Why Combination Therapy is Essential 1. **Ivermectin penetration:** Oral ivermectin achieves high systemic levels and penetrates thick crusts better than topical agents alone. 2. **Mite burden:** The massive number of mites requires repeated dosing (typically 4 doses at days 0, 14, 21, 28) to achieve cure. 3. **Topical synergy:** Concurrent topical permethrin or sulfur 10% (higher concentration than standard 5%) enhances mite kill and removes crusted material. 4. **Crusted material removal:** Gentle debridement of crusts with keratolytic agents (salicylic acid 5–10%) may improve penetration. **High-Yield:** Monotherapy (either ivermectin alone or topical permethrin alone) frequently fails in crusted scabies. Combination therapy is the standard of care. ## Why This Patient Does NOT Have Typical Scabies - **Minimal visible burrows:** Typical scabies presents with linear burrows; crusted scabies shows hyperkeratotic plaques. - **Massive mite burden:** KOH mount showing "numerous mites, eggs, and fecal pellets" is pathognomonic for crusted scabies; typical scabies shows 1–3 mites per specimen. - **Asymptomatic contacts:** In typical scabies, household contacts develop symptoms within 2–4 weeks. Asymptomatic contacts in a nursing home suggest the index patient has crusted scabies (high transmission risk but delayed symptom onset in contacts). - **6-week duration:** Crusted scabies often has a prolonged course before diagnosis due to atypical presentation. **Mnemonic — Crusted Scabies (CRUSTED):** **C**rusted hyperkeratotic plaques | **R**epeated ivermectin dosing (4+ doses) | **U**ncontrolled mite proliferation | **S**ystemic + topical combination therapy | **T**hick burden (1 million+ mites) | **E**lderly/immunocompromised host | **D**angerous institutional transmission. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.